Recent Headlines
Avoid Toxicity and Optimise Treatment with the Improved Lithium Kit from Randox
The new and improved Lithium kit from Randox is intended for the quantitative in vitro determination of Lithium in serum and is suitable for use on a wide range of clinical analysers. - May 27, 2010 - Randox Laboratories
RayBiotech Announces Biomarker Grant Awardees
RayBiotech, Inc., the Protein Array Pioneer Company, has announced the winners of its Biomarker Discovery Pilot Grant program. In total, 18 award recipients were chosen for grants of up to $20,000 each, redeemable for RayBiotech products and services. "By offering these grants," states Dr. - May 06, 2010 - RayBiotech, Inc
GenScript Launches Guaranteed Gene-to-Protein Service Package Following the Technology Breakthrough from OptimumGene™ Gene Optimization
Benefiting from its patent-pending OptimumGene™ gene optimization technology breakthrough which can achieve a 10-fold or greater increase in protein expression, GenScript now offers a first-to-market guaranteed Gene-to-Protein custom service package. - April 28, 2010 - GenScript USA Inc.
Randox Maternal Screening Control Sera - Confidence When It’s Needed Most
Maternal serum screening is widely used to evaluate the risk of certain serious birth defects such as Down’s syndrome and Spina Bifida. - March 28, 2010 - Randox Laboratories
U.S. Patent Granted for the Multimeric Adiponectin ELISA
A United States patent has been granted to Sekisui Medical Corp. (Tokyo, Japan), the inventors of the Multimeric Adiponectin ELISA. The Multimeric Adiponectin ELISA is distributed in the U.S. and Canada exclusively by ALPCO Diagnostics. - March 23, 2010 - ALPCO
Randox Wins Place at House of Lords - Hosted International Trade Competition
RANDOX Laboratories (“Randox”) will represent Northern Ireland when it heads to the House of Lords later this month to compete in the UK-wide 2010 International Trade Awards sponsored by HSBC. The Antrim-based independent medical diagnostics company beat off stiff local competition to... - March 12, 2010 - Randox Laboratories
Biomarker Discovery Grant Deadline Extended
RayBiotech, Inc., today announced that they are extending the deadline for submitting applications for its Biomarker Discovery Pilot Grant program. RayBiotech will now accept applications for the pilot grants through February 22nd, 2010. “The last-minute surge in interest in the grant program has been overwhelming,” said Brett Burkholder, Director of Marketing & Business Development for RayBiotech, Inc. - February 02, 2010 - RayBiotech, Inc
Role of YAP in Cancer Revealed Using EGFR Phosphorylation Array
A study, published in the December 2009 issue of Nature Cell Biology, identified amphiregulin (AREG) as the key effector molecule in YAP-mediated proliferation of breast epithelial cells. Since AREG is a a diffusible, secreted factor, it represents a new potential drug target for cancer. Two antibody arrays from RayBiotech were instrumental in this discovery; one is a unique array detecting phosphorylation of EGFR family receptors at multiple sites. - January 29, 2010 - RayBiotech, Inc
GenScript Recognized as Preferred Contract Supplier of Life Science Products by University of Pennsylvania
GenScript draws attention from UPENN School of Medicine for obtaining best quality products and services. - January 28, 2010 - GenScript USA Inc.
ALPCO Launches Rat and Mouse Proinsulin ELISA Kits
ALPCO Immunoassays has developed two new low-sample volume ELISAs for the quantitative analysis of total proinsulin (I and II) in rats and mice. - January 26, 2010 - ALPCO
GenScript Launches Click Peptide Services
GenScript’s click peptide service aims to handle difficult peptide you intended to study. - January 21, 2010 - GenScript USA Inc.
GenScript’s Presence in Japan Relocated from Osaka to Tokyo
GenScript plans to expand its Japanese market from its capital. - January 21, 2010 - GenScript USA Inc.
RayBiotech Introduces Multiplex ELISA Detecting 200 Human Proteins
RayBiotech, the Protein Array Pioneer Company, has just introduced the Quantibody® Human Cytokine Array 4000 (or Human Q4000, catalog number QAH-CAA-4000), which can quantitatively detect expression of 200 different proteins in a single experiment. The kit consists of 5 different quantitative... - December 12, 2009 - RayBiotech, Inc
ALPCO Diagnostics and BioPorto Diagnostics Enter Into Distribution Partnership
ALPCO Diagnostics has taken on the responsibility to promote and sell BioPorto Diagnostics’ immunoassays on the US and Canadian markets. The primary product focus is BioPorto’s unrivalled portfolio of human and animal immunoassays for measuring NGAL – the breakthrough kidney... - December 08, 2009 - ALPCO
Rapid Drugs of Abuse Screening from Rando
Randox has developed an innovative multi-marker drugs of abuse testing procedure for rapid drug screening programmes. The Drugs of Abuse (DoA) biochips permit the analysis of up to 10 drug classes from a single patient sample providing rapid and accurate testing. Randox biochip array technology is... - November 26, 2009 - Randox Laboratories
Randox Unveils Cardiac Care Technology at Major European Medical Event
RANDOX Laboratories (“Randox”), the Antrim-based independent global diagnostics company, will today unveil a revolutionary new cardiac machine at the world’s largest medical trade fair being held this week in Dusseldorf, Germany. - November 21, 2009 - Randox Laboratories
New Software Bundle: MetaServer and MetaClient
With the software bundle MetaServer/ MetaClient a new level of patient data management has been introduced by MetaSystems. The software bundle, which comes as a part of the new Ikaros and Isis Versions 5.4, is a comprehensive dashboard to maintain, filter, search, and summarize case and image data from all systems in the network. - November 18, 2009 - MetaSystems
News at MEDICA: ALPCO Announces the Launch of Several New Products in 2009
ALPCO will return to MEDICA, showcasing these new immunoassay kits, which cement the company's perennial committment to serving the demands of the pre-clinical research market. This will be ALPCO's fourth year at MEDICA as part of the “Best of New England” consortium of companies, located in the US pavilion in Halle 3, D15-4. - November 16, 2009 - ALPCO
Randox Launch New Aldolase Test
Randox have further expanded their assay portfolio with the launch of a new highly accurate Aldolase test aimed at diagnosing patients who have muscle or liver damage. Aldolase is an enzyme that helps convert glucose into energy and is found throughout the body but is primarily found in high... - October 29, 2009 - Randox Laboratories
Drugs of Abuse Reagents on Randox Clinical Chemistry Analysers
Randox have launched Drugs of Abuse (DoA) reagents for use on the RX Series of Clinical Chemistry Analysers. You can now detect 10 drugs of abuse in human urine on quality systems offering time, labour and cost savings. Drug abuse is a serious problem worldwide and its prevalence is increasing... - October 17, 2009 - Randox Laboratories
Advanced Liquid CO2 Assay for Rx Clinical Chemistry Analysers from Randox
Randox announce a significant improvement in liquid CO2 measurement, with improved reagent stability for on board use, calibration and shelf life on the RX Series clinical chemistry analysers. Carbon dioxide (CO2) is a metabolic waste product of cellular respiration. Elevated levels of CO2 in the... - October 17, 2009 - Randox Laboratories
Randox: Winner of Manufacturing Excellence Award for Product Innovation
The Institute of Mechanical Engineers has awarded Randox Laboratories the Award for Product Innovation at the Manufacturing Excellence Awards held on 25th June 2009 in London. The Manufacturing Excellence Awards are an annual event that recognises the very best in the UK manufacturing industry and... - October 17, 2009 - Randox Laboratories
ALPCO Introduces Immundiagnostik Bone Sialoprotein (BSP) ELISA to North America
ALPCO Diagnostics introduces Immundiagnostik's Bone Sialoprotein ELISA to North America. The BSP ELISA exhibits outstanding sensitivity and specificity for the underglycosylated or carbohydrate deficient Bone Sialoprotein. - October 15, 2009 - ALPCO
A Multitude of Choice in Antimicrobial Screening
Randox have developed three biochip arrays for the detection of a variety of antimicrobial agents. These arrays enable simultaneous multi-analyte testing of up to 12 antimicrobials from a single sample. Antimicrobial Array I tests for sulphonamides, Array II for general antibiotics and Array III... - October 14, 2009 - Randox Laboratories
Revolutionary Randox Technology Offers Multiple Cardiac Tests Within Minutes
Randox Laboratories have launched a revolutionary new Biochip Analyser that will save cardiac patients lives by providing immediate diagnosis at the point of care. Cardiovascular disease is a progressive and complicated condition, covering a spectrum of symptoms and biochemical processes which are... - October 14, 2009 - Randox Laboratories
ALPCO and Athera Biotechnologies Sign Distribution Agreement in North America
ALPCO Diagnostics, a leading developer and distributor of high quality immunoassay kits, is pleased to announce that they have signed with Athera Biotechnologies as their new distribution channel in the North America. Sean Conley, COO of ALPCO, said “We are very excited about the... - October 06, 2009 - ALPCO
FDA Awards Biosearch Technologies $3.4 Mm Contract for Bioterror and Food Pathogen Detection
Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has been awarded a contract by the Food and Drug Administration (FDA) for the development of rapid... - October 02, 2009 - Biosearch Technologies
RayBiotech to Award Biomarker Discovery Grants
RayBiotech, Inc., today announced today the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services to conduct their proposed biomarker research, which would potentially be sufficient to generate preliminary data for additional grant funding. - September 26, 2009 - RayBiotech, Inc
ALPCO Launches GLP-1 (Active 7-36) and (7-36 and 9-36) ELISA kits
ALPCO Immunoassays is pleased to introduce two new ELISA kits for research use for measurement of the active (7-36) and combined (7-36 and 9-36) GLP-1 fragments. - September 23, 2009 - ALPCO
GenScript Established Biology Research Collaboration with Roche
GenScript expands its drug discovery services to assay development. - September 12, 2009 - GenScript USA Inc.
GenScript Launches Antibody Sequencing Service Geared Toward Innovation
GenScript’s antibody sequencing service aims to accelerate antibody drug discovery and patent applications. - September 05, 2009 - GenScript USA Inc.
GenScript Launches 20% Off Campaign Celebrating the 5th Anniversary of Peptide Service
GenScript celebrates its 5th anniversary for its peptide services by giving customers 20% off for standard peptide synthesis and modifications. - August 23, 2009 - GenScript USA Inc.
GenScript Expands Its THE™ Elite Antibody Series
GenScript adds THE™ Anti-DYKDDDDK mAb to the THE™ antibody series. - August 18, 2009 - GenScript USA Inc.
ALPCO Appoints Stratech Scientific as Their New Distribution Channel in the UK
Stratech Scientific is a distributor of high quality products for research laboratories throughout the UK and Europe. ALPCO Diagnostics is a leading developer and distributor of high quality immunoassay kits in the US. The two companies feel that their mutual commitment to offering quality products in the life science research area will be the basis for a strong partnership. - August 13, 2009 - ALPCO
ALPCO Launches Mouse HMW and Total Adiponectin ELISA
ALPCO Diagnostics has introduced a Mouse HMW Adiponectin ELISA kit that facilitates the testing process for this biomarker. - August 07, 2009 - ALPCO
GenScript Upgrades Plasmid Production Platform to Deliver Potent Plasmids
GenScript upgrades its plasmid production platform to enable wider scope downstream applications. - August 07, 2009 - GenScript USA Inc.
GenScript Raises $15M for Drug Discovery and Development Services Expansion —Kleiner Perkins Invests in Biology CRO Business
GenScript Inc. received $15M investment led by Kleiner Perkins Caufield & Byers (KPCB) to expand its biology and bio-reagent services in drug discovery and development. - June 26, 2009 - GenScript USA Inc.
RayBiotech Now Offers Nearly 500 ELISA Kits
RayBiotech, the Protein Array Pioneer Company, has just increased its product line of different ELISA kits to 495, including ones detecting cytokines, chemokines, growth factors, angiogenic factors and adipokines in human, mouse, and rat samples. - June 03, 2009 - RayBiotech, Inc
Advanced Biotechnologies, Inc. (ABI) Adds UV-Inactivated Purified Whole Virus Product to Aid in Research of Human Influenza
ABI adds (H2N2) Purified Whole Virus, UV-Inactivated for use in H2N2 subtype-specific protein-based testing. Catalog # 10-126-000 - June 01, 2009 - Advanced Biotechnologies, Inc.
Advanced Biotechnologies, Inc. (ABI) Adds Cytomegalovirus (CMV) β-PL Inactivated Purified Whole Virus Product
Cytomegalovirus (CMV) AD169, Purified Whole Virus was inactivated by treatment with Beta-propiolactone (β-PL). β-PL is a DNA alkylating agent that has been shown to be effective in the inactivation of a virus. It chemically modifes viral DNA without affecting the immunogenicity or protein... - May 30, 2009 - Advanced Biotechnologies, Inc.
Genscript Offers Free Bio-Reagent Sample Bundles
GenScript offers high quality bundled bio-reagent samples to appreciate customers and assist in biology research under current tough economic condition. - May 10, 2009 - GenScript USA Inc.
GenScript Seeks Long-Term Collaboration Opportunities by Offering Special Partnership Promotion for Gene Synthesis
Internationally recognized biology contract research organization GenScript Corporation announces its special partnership promotion for gene synthesis service, which aims to establish a long-term, high-volume, and preferred vendor contract with its partners by offering them specially discounted... - April 22, 2009 - GenScript USA Inc.
Australian Pharmaceutical Company Breaks Down Barriers to Conception for Would be Mums Around the World
Australian pharmaceutical company Sasmar has released their conception product following three years of development in conjunction with fertility experts from respected university hospitals in the USA. The pink and gold packed Conceive Plus product will be on shelves in over thirty countries. - March 21, 2009 - SASMAR Sprl
Quantimetrix Corporation Releases New Package Design
Quantimetrix Corporation announces its newly redesigned product packaging. - March 05, 2009 - Quantimetrix Corporation
New Hope in Cancer Treatment for Dogs: PharmaCom BioVet’s Veterinary Oncology Treatment Centers
“We lost three of our Siberian Huskies …close family members, to cancer.” The Bertholds vowed, “We would spend the rest of our lives for the sake of our living dogs — in addition to all other dogs — attempting to find better, improved cancer treatments.” PharmaCom BioVet is truly “a union of compassion and technology.” - March 03, 2009 - PharmaCom BioVet
Announcing the Launch of the New 25-OH Vitamin D ELISA: Exceptional Correlation to LC-MS/MS in a User-Friendly, Automatable ELISA Format
Serum measurements of 25-OH vitamin D by ELISA are easy and cost-effective for research laboratories who do not have access to the gold standard method, LC-MS/MS with the new 25-OH vitamin D ELISA kit offered by ALPCO. - February 27, 2009 - ALPCO
BellBrook Labs Announces a Kinase/ATPase Assay That is "2" Sensitive
The Transcreener ADP2 FP Assay is a homogenous fluorescence polarization assay that enables the facile detection and screening of established drug targets including protein and lipid kinases as wells as emerging targets such as heat shock proteins and other ATPases. - October 15, 2008 - BellBrook Labs
Genomic Nanosystems Announces Exclusive Licensing Agreement to Sequenom for the Right to Use Digital PCR in Prenatal Testing and Mass Spectrometry
Genomic Nanosystems, LLC, today announced that it has granted an exclusive license to Sequenom, Inc. (Nasdaq: SQNM) for the right to use Digital PCR in noninvasive prenatal research and diagnostics on a technology, platform and sample independent basis, and has granted the exclusive right to use... - September 22, 2008 - Genomic Nanosystems
Genomic Nanosystems Announced Today That It Has Received the Exclusive Patent Rights for Clonal Amplification and Digital PCR (Polymerase Chain Reaction) from Cytonix
Genomic Nanosystems, LLC has received the exclusive patent rights to U.S. patent No. 6,143,496. Patent ‘496 was first to describe methods for detecting single nucleic acid molecules after one amplification step, for amplifying one or more nucleic acids in nano-scale volumes or regions, and for carrying out digital PCR. - June 01, 2008 - Genomic Nanosystems
Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board
Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals